BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 9322886)

  • 1. Deletion variants within the NF-kappaB activation domain of the LMP1 oncogene in acquired immunodeficiency syndrome-related large cell lymphomas, in prelymphomas and atypical lymphoproliferations.
    Berger C; Brousset P; McQuain C; Knecht H
    Leuk Lymphoma; 1997 Jul; 26(3-4):239-50. PubMed ID: 9322886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion variants within the NF-kappa B activation domain of the LMP1 oncogene prevail in acquired immunodeficiency syndrome-related large cell lymphomas and human immunodeficiency virus-negative atypical lymphoproliferations.
    Knecht H; Raphaël M; McQuain C; Rothenberger S; Pihan G; Camilleri-Broët S; Bachmann E; Kershaw GR; Ryan S; Kittler EL; Quesenberry PJ; Schlaifer D; Woda BA; Brousset P
    Blood; 1996 Feb; 87(3):876-81. PubMed ID: 8562956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural 30 base pair and 69 base pair deletion variants of the LMP1 oncogene do stimulate NF-kappaB-mediated transcription.
    Rothenberger S; Bachmann E; Berger C; McQuain C; Odermatt BF; Knecht H
    Oncogene; 1997 May; 14(17):2123-6. PubMed ID: 9160892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High frequency of a 30-bp deletion of Epstein-Barr virus latent membrane protein 1 gene in primary HIV non-Hodgkin's brain lymphomas.
    Vallat-Decouvelaere AV; Bretel MA; Vassias I; Laplanche JL; Polivka M; Wassef M; Brunet M; Thiebaut JB; Gosselin B; Morinet F; Mikol J
    Neuropathol Appl Neurobiol; 2002 Dec; 28(6):471-9. PubMed ID: 12445163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Functional analysis of Epstein-Barr virus latent membrane proteins (LMP1) in patients with limphoproliferative disorders].
    Smirnova KV; Diduk SV; Gurtsevich VÉ
    Biomed Khim; 2011; 57(1):114-26. PubMed ID: 21516783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients.
    Liebowitz D
    N Engl J Med; 1998 May; 338(20):1413-21. PubMed ID: 9580648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular epidemiology of deletions and mutations of the latent membrane protein 1 oncogene of the Epstein-Barr virus in posttransplant lymphoproliferative disorders.
    Smir BN; Hauke RJ; Bierman PJ; Gross TG; d'Amore F; Anderson JR; Greiner TC
    Lab Invest; 1996 Oct; 75(4):575-88. PubMed ID: 8874388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus latent membrane protein-1 oncogene deletion in post-transplantation lymphoproliferative disorders.
    Scheinfeld AG; Nador RG; Cesarman E; Chadburn A; Knowles DM
    Am J Pathol; 1997 Sep; 151(3):805-12. PubMed ID: 9284829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent expression of the tumor necrosis factor receptor-associated factor 1 in latent membrane protein 1-positive posttransplant lymphoproliferative disease and HIV-associated lymphomas.
    Murray PG; Swinnen LJ; Flavell JR; Ragni MV; Baumforth KR; Toomey SM; Filipovich AH; Lowe D; Schnell CS; Johl J; Gulley M; Young LS; Ambinder RF
    Hum Pathol; 2001 Sep; 32(9):963-9. PubMed ID: 11567226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of latent membrane protein 1 of Epstein-Barr virus and BCL-2 oncoprotein in acquired immunodeficiency syndrome-related primary brain lymphomas.
    Camilleri-Broët S; Davi F; Feuillard J; Bourgeois C; Seilhean D; Hauw JJ; Raphaël M
    Blood; 1995 Jul; 86(2):432-5. PubMed ID: 7605982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of latent membrane protein 1 in patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan.
    Tabata YHibi S; Teramura T; Kuriyama K; Yagi T; Todo S; Sawada T; Imashuku S
    Leuk Lymphoma; 2000 Jul; 38(3-4):373-80. PubMed ID: 10830744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.
    Eliopoulos AG; Stack M; Dawson CW; Kaye KM; Hodgkin L; Sihota S; Rowe M; Young LS
    Oncogene; 1997 Jun; 14(24):2899-916. PubMed ID: 9205097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of oncogenic properties and nuclear factor-kappaB activity of latent membrane protein 1 natural variants from Hodgkin's lymphoma's Reed-Sternberg cells and normal B-lymphocytes.
    Faumont N; Chanut A; Benard A; Cogne N; Delsol G; Feuillard J; Meggetto F
    Haematologica; 2009 Mar; 94(3):355-63. PubMed ID: 19211641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the LMP1 oncoprotein in the EBV negative Hodgkin's disease cell line L-428 is associated with Reed-Sternberg cell morphology.
    Knecht H; McQuain C; Martin J; Rothenberger S; Drexler HG; Berger C; Bachmann E; Kittler EL; Odermatt BF; Quesenberry PJ
    Oncogene; 1996 Sep; 13(5):947-53. PubMed ID: 8806684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LMP1 signaling and activation of NF-kappaB in LMP1 transgenic mice.
    Thornburg NJ; Kulwichit W; Edwards RH; Shair KH; Bendt KM; Raab-Traub N
    Oncogene; 2006 Jan; 25(2):288-97. PubMed ID: 16247482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus induces expression of the putative oncogene Bcl-3 through activation of the nuclear factor-kappaB.
    Nakamura H; Ishii C; Suehiro M; Iguchi A; Kuroda K; Shimizu K; Shimizu N; Imadome K; Yajima M; Fujiwara S
    Virus Res; 2008 Feb; 131(2):170-9. PubMed ID: 17963943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational hot spots within the carboxy terminal region of the LMP1 oncogene of Epstein-Barr virus are frequent in lymphoproliferative disorders.
    Knecht H; Bachmann E; Brousset P; Rothenberger S; Einsele H; Lestou VS; Delsol G; Bachmann F; Ambros PF; Odermatt BF
    Oncogene; 1995 Feb; 10(3):523-8. PubMed ID: 7845677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and functional analysis of the Epstein-Barr virus LMP1 oncogene promoter in lymphoproliferative diseases.
    Rothenberger S; Bachmann E; Knecht H
    Exp Hematol; 1997 Dec; 25(13):1326-32. PubMed ID: 9406991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The NPC derived C15 LMP1 protein confers enhanced activation of NF-kappa B and induction of the EGFR in epithelial cells.
    Miller WE; Cheshire JL; Baldwin AS; Raab-Traub N
    Oncogene; 1998 Apr; 16(14):1869-77. PubMed ID: 9583684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleotide sequences and functions of the Epstein-Barr virus latent membrane protein 1 genes isolated from salivary gland lymphoepithelial carcinomas.
    Jen KY; Higuchi M; Cheng J; Li J; Wu LY; Li YF; Lin HL; Chen Z; Gurtsevitch V; Fujii M; Saku T
    Virus Genes; 2005 Mar; 30(2):223-35. PubMed ID: 15744579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.